 |
Enhancing Drug Bioavailability & Solubility
January 25, 2012—January 26, 2012
Boston, MA, USA
Novel Immunotherapeutics Summit
January 30, 2012—January 31, 2012
San Diego, CA, USA
Cool Chain Logistics Europe 2012
January 30, 2012—February 1, 2012
Basil, Switzerland
Computer System Validation - Reduce Costs and Avoid 483s
February 2, 2012—February 3, 2012
Scottsdale, AZ, USA
Pharmaceutical Parallel Trade
February 6, 2012—February 7, 2012
London, United Kingdom 
|
|
|
 |
 |
|
Global Market Boom for Generic Drugs
The generic-drugs market is poised to experience strong growth as key blockbuster products go off patent, but companies looking to benefit from this will have to be careful about the product segments where they compete, according to a report from Frost & Sullivan. 
FDA Recommends Three Drug User Fee Programs
On Jan. 13, 2012, FDA announced it had completed, and transmitted to Congress, its recommendations for three user fee programs including the fifth authorization of the Prescription Drug User Fee Act and programs for human generic drugs and biosimilar biological products.
AstraZeneca and IMS Health Announce Data and Research Collaboration
On Jan. 11, 2012, AstraZeneca and IMS Health announced a three-year collaboration to use real-world healthcare data from Europe to guide AstraZeneca’s discovery and clinical development programs. |
 Photoelectric sensor detects clear objects
Banner Engineering has added the Q26 Series photoelectric sensor to its line of clear-object detection sensors. The unit’s polarized retro coaxial design enables it to detect clear, translucent, or opaque objects, including mirrorlike surfaces. The design also enables precise leading-edge detection, thus making the detector appropriate in high-speed applications. The sensor operates at short distances and is suitable for pharmaceutical vial-filling operations.
The Q26 has a compact cubic shape intended to allow users to install it quickly in tight locations. The unit includes an LO–DO switch that enables operators to control the output type. A single-turn potentiometer lets users adjust detection sensitivity. The Q26 unit also communicates its operation and connection status, thus allowing the user to ensure reliable sensor performance.
The photoelectric sensor operates with a response speed of 250 µs. The device is also protected against damage from potential miswiring during installation and transient voltage spikes during operation. |
|
|
 |
|
The CDMO Almac has opened a new £3-million ($4.6 million), 30,000-ft2 building at its Craigavon, United Kingdom, headquarters. The operations and departments at the new location will include packaging and distribution of medicinal supplies for clinical studies, business development, marketing, human resources, and information systems. Read More
Advertisement:
Learn how you can use analytical tools to make scientific discoveries not possible by other means. SYNAPT G2-S from Waters gives you access to the highest levels of information content from your most analytically challenging samples. The combination of StepWave ion optics, QuanTof analyzer, and High Definition MS technologies maximize your chance of success to deliver all-inclusive qualitative and quantitative performance.  Find out more |
In addition, Almac's sciences business unit and the biopharmaceutical company MGB Biopharma have entered into a collaboration where Almac will manufacture the production of their lead gram positive antibacterial compound MGB-BP3. The compound is a DNA minor groove binder and is currently in preclinical development with IND filing targeted for the third quarter of 2012. Read More
Advertisement:
North America's largest chemical trade show, is an all encompassing global chemical event featuring a trade show floor, conference sessions, and networking receptions. This premier annual event will bring together motivated buyers and sellers in the fine, specialty and custom chemical industry for 3 days from February 15-17, 2012 at the Morial Convention Center in New Orleans, LA. Informex will provide numerous opportunities to make new connections, firm up projects with existing suppliers/clients, and learn about the latest trends in the chemical industry.  Register today! |
Janssen Research & Development has opened Janssen Labs, a 30,000-ft2 life-sciences innovation center located within the company's Janssen West Coast Research Center in San Diego, California. The expansion is designed to provide a capital efficient, flexible lab environment for start-up companies pursuing new technologies and research platforms to advance medical care. To date, the management team of Janssen Labs has received and reviewed more than 100 applications. Companies are evaluated based on criteria such as the scope of science and/or technology, area of significant medical or market need, credible science/technology team, demonstrated financial solvency, as well as several other areas. The applying companies represent the biotechnology, pharmaceutical, medical devices, instrumentation, and diagnostics sectors. The facility can accommodate a maximum of 18 to 20 companies, and the application and assessment process will continue throughout 2012. Read More
NantWorks, a technology company, has announced plans to locate a new pharmaceutical manufacturing plant in Terre Haute, Indiana. The company plans to invest $85.5 million to redevelop the former Pfizer facility in Terre Haute. The new manufacturing plant, which is expected to be operational in 2015, will produce critical-care injectable and oncological drugs. NantWorks was founded by Patrick Soon-Shiong, who previously developed two pharmaceutical companies: APP and Abraxis Biosciences. Read More
Novartis has announced plans to restructure its US general medicines business in the wake of the patent expiration of Diovan (valsartan), an antihypertensive drug, and the reduction in demand for the antihypertensive Rasilez/Tekturna (aliskiren) following the termination of a clinical study. The plans will result in the reduction of 1960 positions (1630 positions in its sales force and 330 support and headquartered positions). The restructuring is expected to result in an exceptional charge of approximately $160 million to be recognized in the results for the first quarter of 2012. The company hopes to produce full-year savings of approximately $450 million as of 2013, about half of which is expected to be realized in 2012 due to reorganization timelines. Read More
Takeda has announced plans to restructure following its October 2011 acquisition of Nycomed. The restructuring plans include a reduction of its global workforce by approximately 2800 (2100 in Europe and 700 in the US) positions by the end of fiscal year 2015 across the functions of R&D, commercial, operations, and general and administrative. Read More
In other news:
Carbogen Amcis has acquired Creapharm Parenterals.
Constellation Pharmaceuticals has formed an epigenetics drug-discovery and development collaboration with Genentech.
FEI has announced a collaboration with the National Institutes of Health to create a laboratory for structural biology research.
Fleming Pharmaceuticals has sold select branded products to Valeant and is considering options for its Midwestern manufacturing capability.
Genzyme has received EMA approval of its manufacturing plant in Framingham, Massachusetts, for the production of Fabrazyme (agalsidase beta).
Islet Sciences has selected NeoStem's manufacturing subsidiary Progenitor Cell Therapy for a product manufacturing agreement.
Molecular Profiles has invested £9-million ($13.9 million) in the construction of a new manufacturing facility.
Paragon Bioservices received a multimillion-dollar US Department of Defense contract for filovirus vaccine development and manufacturing.
Particle Sciences adds Brabender Pharma extruder to expand extrusion capabilities.
Quintiles has formed a new cancer biomarker R&D company.
SignaBlok has been awarded a US Department of Defense contract to support new technology to combat sepsis.
Do you have news to report on facility expansions, contracts, service agreements, mergers, acquisitions, or personnel appointments? Send press releases to [email protected] |
|
|
|
|
|
|
|
|
API Manufacturing
What is the most important change that has influenced chemical API manufacturing during the past 10 years?
|
View the poll archive. |
|
|
|
